Hamidouche K

References (5)

Title : Donecopride, a Swiss army knife with potential against Alzheimer's disease - Rochais_2020_Br.J.Pharmacol_177_1988
Author(s) : Rochais C , Lecoutey C , Hamidouche K , Giannoni P , Gaven F , Cem E , Mignani S , Baranger K , Freret T , Bockaert J , Rivera S , Boulouard M , Dallemagne P , Claeysen S
Ref : British Journal of Pharmacology , 177 :1988 , 2020
Abstract :
PubMedSearch : Rochais_2020_Br.J.Pharmacol_177_1988
PubMedID: 31881553

Title : Co-modulation of an allosteric modulator of nicotinic receptor-cholinesterase inhibitor (galantamine) and a 5-HT4 receptor agonist (RS-67333): effect on scopolamine-induced memory deficit in the mouse - Freret_2017_Psychopharmacology.(Berl)_234_2365
Author(s) : Freret T , Lelong-Boulouard V , Lecouflet P , Hamidouche K , Dauphin F , Boulouard M
Ref : Psychopharmacology (Berl) , 234 :2365 , 2017
Abstract :
PubMedSearch : Freret_2017_Psychopharmacology.(Berl)_234_2365
PubMedID: 28631100

Title : Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease - Yahiaoui_2016_Eur.J.Med.Chem_121_283
Author(s) : Yahiaoui S , Hamidouche K , Ballandonne C , Davis A , de Oliveira Santos JS , Freret T , Boulouard M , Rochais C , Dallemagne P
Ref : Eur Journal of Medicinal Chemistry , 121 :283 , 2016
Abstract :
PubMedSearch : Yahiaoui_2016_Eur.J.Med.Chem_121_283
PubMedID: 27266998

Title : Chronic activation of 5-HT4 receptors or blockade of 5-HT6 receptors improve memory performances - Quiedeville_2015_Behav.Brain.Res_293_10
Author(s) : Quiedeville A , Boulouard M , Hamidouche K , Da Silva Costa-Aze V , Nee G , Rochais C , Dallemagne P , Fabis F , Freret T , Bouet V
Ref : Behavioural Brain Research , 293 :10 , 2015
Abstract :
PubMedSearch : Quiedeville_2015_Behav.Brain.Res_293_10
PubMedID: 26187692

Title : Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride - Rochais_2015_J.Med.Chem_58_3172
Author(s) : Rochais C , Lecoutey C , Gaven F , Giannoni P , Hamidouche K , Hedou D , Dubost E , Genest D , Yahiaoui S , Freret T , Bouet V , Dauphin F , Sopkova de Oliveira Santos J , Ballandonne C , Corvaisier S , Malzert-Freon A , Legay R , Boulouard M , Claeysen S , Dallemagne P
Ref : Journal of Medicinal Chemistry , 58 :3172 , 2015
Abstract :
PubMedSearch : Rochais_2015_J.Med.Chem_58_3172
PubMedID: 25793650